George Yancopoulos - PDFSEARCH.IO - Document Search Engine

George Yancopoulos
Results: 8

#	Item
1	TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc Add to Reading List Source URL: www.regeneron.com Language: English - Date: 2015-04-07 14:06:33 Biotechnology Pharmacy Clinical research Regeneron Monoclonal antibodies George Yancopoulos Lexicon Pharmaceuticals Drug discovery Biopharmaceutical Pharmaceutical sciences Pharmacology Pharmaceutical industry
2	TRADE RELEASE NOT FOR WIRE DISTRIBUTION Regeneron Hires Brian Zambrowicz, Ph.D., as Vice President of Functional Genomics and Chief of VelociGene® Operations TARRYTOWN, N.Y. AprilRegeneron Pharmaceuticals, Inc Add to Reading List Source URL: www.regeneron.com Language: English - Date: 2015-04-07 14:06:33 Biotechnology Pharmacy Clinical research Regeneron Monoclonal antibodies George Yancopoulos Lexicon Pharmaceuticals Drug discovery Biopharmaceutical Pharmaceutical sciences Pharmacology Pharmaceutical industry
3	Leading Figures from Drug Discovery and Life Sciences to Gather for MipTec 2012 in Basel The largest European conference on drug discovery, MipTec, continues to grow and offers a high‐ Add to Reading List Source URL: www.congrex-switzerland.com Language: English - Date: 2013-10-18 15:42:31 Pharmaceutical industry George Yancopoulos Health Science Pharmacology BioValley Rhine basin
4	ASTELLAS LICENSES REGENERON’S VELOCIMMUNE® TECHNOLOGY FOR DISCOVERING HUMAN MONOCLONAL ANTIBODIES Tokyo, Japan and Tarrytown, NY – (March 30, 2007) – Astellas Pharma Inc. (“Astellas”; Headquarters: Tokyo, Japa Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:30:47 Immune system Medicine Regeneron Monoclonal antibodies Astellas Pharma Biopharmaceutical Polyclonal antibodies Monoclonal antibody therapy George Yancopoulos Biotechnology Immunology Biology
5	April 3, 2014 Regeneron Announces Initiative for STEM Education in Hudson Valley Fellowship Program in Collaboration with NASA, Teachers College, Columbia University and STEM Education Leadership Center TARRYTOWN, N.Y., Add to Reading List Source URL: files.shareholder.com Language: English George Yancopoulos Regeneron
6	Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Dermatologic and Ophthalmic Drugs Advisory Committee June 17, 2011 Add to Reading List Source URL: www.fda.gov Language: English Pharmaceutical sciences Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research Ketorolac Vascular endothelial growth factor George Yancopoulos Macular degeneration Food and Drug Administration Medicine Health
7	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research George Yancopoulos Regeneron Ketorolac Food and Drug Administration Pharmaceutical sciences Clinical research
8	The committee will discuss saxagliptin tablets, by Bristol-Myers Squibb, for the treatment of hyperglycemia in adults with type 2 diabetes mellitus Add to Reading List Source URL: www.fda.gov Language: English Pharmacology Dermatologic and Ophthalmic Drugs Advisory Committee Center for Drug Evaluation and Research George Yancopoulos Regeneron Ketorolac Food and Drug Administration Pharmaceutical sciences Clinical research